NHS England has informed us that data on the applications approved through the Cancer Drugs Fund (CDF) are reported monthly by the four regional/area teams that operationally manage the fund. This information is published quarterly on NHS England's website. Alongside this, financial spend data are received monthly from each of the NHS England area teams and reviewed at a monthly national CDF team meeting. This information allows NHS England to review invoiced spend to date (from NHS trusts), review each region's predictions for end of year spend and refine national predictions of end of year spend. The national prediction of spend is developed by NHS England's Chemotherapy Clinical Reference Group. It is informed, by data on applications received to date as well as predications of likely future demand and costs associated with the drugs available within the national CDF priority list. We understand that summary expenditure information showing invoiced spend to date, regional predicted spend and the current national predicted spend on the CDF will be published by NHS England in the next few weeks.